Cargando…

Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?

BACKGROUND: Stent manufacturers always record stent shortening data while they do not record stent elongation data. The aim of this study is to identify both stent shortening and elongation occurring after deployment in the coronary arteries and know their percentage. RESULTS: The length of coronary...

Descripción completa

Detalles Bibliográficos
Autores principales: Algowhary, Magdy, Abdelmegid, Mohammed Aboel-Kassem F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128949/
https://www.ncbi.nlm.nih.gov/pubmed/34002293
http://dx.doi.org/10.1186/s43044-021-00170-9
_version_ 1783694205077422080
author Algowhary, Magdy
Abdelmegid, Mohammed Aboel-Kassem F.
author_facet Algowhary, Magdy
Abdelmegid, Mohammed Aboel-Kassem F.
author_sort Algowhary, Magdy
collection PubMed
description BACKGROUND: Stent manufacturers always record stent shortening data while they do not record stent elongation data. The aim of this study is to identify both stent shortening and elongation occurring after deployment in the coronary arteries and know their percentage. RESULTS: The length of coronary stents was measured by intravascular ultrasound (IVUS) by (1) edge-to-edge (E-E) length, measured from the appearance of the first distal strut to the last proximal strut, and (2) area-to-area (A-A) length, measured from the first distal struts seen at more than one IVUS quadrant to the last proximal struts seen at more than one IVUS quadrant. Stent shortening was defined as both E-E and A-A lengths were shorter than the manufacturer box-stated length (shortened group). Stent elongation was defined as both E-E and A-A lengths were longer than the manufacturer box-stated length (elongated group), otherwise unchanged group. Consecutive 102 stents deployed in ischemic patients were included. Stent elongation was detected in 67.6% (69 stents), and shortening was detected in 15.7% (16 stents), while unchanged stents were detected in 16.7% (17 stents). Although the 3 groups had similar box-stated length and predicted foreshortened length, they had significantly different measurements by IVUS, p<0.001 for each comparison. Differences from box-stated length were 1.9±1.4mm, −1.4±0.4mm, and 0.4±0.3mm, respectively, p<0.001. The elongated group had significantly longer differences from the corresponding box-stated and predicted foreshortened lengths, while the shortened group had significantly shorter differences from the corresponding box-stated length and similar foreshortened length. By multinomial regression analysis, the plaque-media area and stent deployment pressure were the independent predictors of the stent length groups, p=0.015 and p=0.026, respectively. CONCLUSIONS: Change in stent length is not only shortening—as mentioned in the manufacturer documents—but also stent elongation. Stent elongation is dominant, and the most important predictors of longitudinal stent changes are plaque-media area and stent deployment pressure.
format Online
Article
Text
id pubmed-8128949
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81289492021-05-27 Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant? Algowhary, Magdy Abdelmegid, Mohammed Aboel-Kassem F. Egypt Heart J Research BACKGROUND: Stent manufacturers always record stent shortening data while they do not record stent elongation data. The aim of this study is to identify both stent shortening and elongation occurring after deployment in the coronary arteries and know their percentage. RESULTS: The length of coronary stents was measured by intravascular ultrasound (IVUS) by (1) edge-to-edge (E-E) length, measured from the appearance of the first distal strut to the last proximal strut, and (2) area-to-area (A-A) length, measured from the first distal struts seen at more than one IVUS quadrant to the last proximal struts seen at more than one IVUS quadrant. Stent shortening was defined as both E-E and A-A lengths were shorter than the manufacturer box-stated length (shortened group). Stent elongation was defined as both E-E and A-A lengths were longer than the manufacturer box-stated length (elongated group), otherwise unchanged group. Consecutive 102 stents deployed in ischemic patients were included. Stent elongation was detected in 67.6% (69 stents), and shortening was detected in 15.7% (16 stents), while unchanged stents were detected in 16.7% (17 stents). Although the 3 groups had similar box-stated length and predicted foreshortened length, they had significantly different measurements by IVUS, p<0.001 for each comparison. Differences from box-stated length were 1.9±1.4mm, −1.4±0.4mm, and 0.4±0.3mm, respectively, p<0.001. The elongated group had significantly longer differences from the corresponding box-stated and predicted foreshortened lengths, while the shortened group had significantly shorter differences from the corresponding box-stated length and similar foreshortened length. By multinomial regression analysis, the plaque-media area and stent deployment pressure were the independent predictors of the stent length groups, p=0.015 and p=0.026, respectively. CONCLUSIONS: Change in stent length is not only shortening—as mentioned in the manufacturer documents—but also stent elongation. Stent elongation is dominant, and the most important predictors of longitudinal stent changes are plaque-media area and stent deployment pressure. Springer Berlin Heidelberg 2021-05-17 /pmc/articles/PMC8128949/ /pubmed/34002293 http://dx.doi.org/10.1186/s43044-021-00170-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Algowhary, Magdy
Abdelmegid, Mohammed Aboel-Kassem F.
Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?
title Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?
title_full Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?
title_fullStr Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?
title_full_unstemmed Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?
title_short Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?
title_sort longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128949/
https://www.ncbi.nlm.nih.gov/pubmed/34002293
http://dx.doi.org/10.1186/s43044-021-00170-9
work_keys_str_mv AT algowharymagdy longitudinalstentelongationorshorteningafterdeploymentinthecoronaryarterieswhichisdominant
AT abdelmegidmohammedaboelkassemf longitudinalstentelongationorshorteningafterdeploymentinthecoronaryarterieswhichisdominant